OS Therapies Inc — Form 8-K
Filed August 21, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
OS Therapies Incorporated entered an Open Market Sale Agreement with Jefferies LLC dated August 21, 2026, to issue and sell up to $75 million of common shares at-the-market (ATM). The shares are to be offered and sold on a prospective basis through Jefferies acting as sales agent or principal, with a 3% selling commission. The agreement is effective through August 25, 2028 (the expiration date of the underlying Form S-3 registration statement, File No. 333-289443).
Why this rating
ATM offering of $75M represents 151% of company's ~$49.6M market cap—massive dilution risk. While typical for capital-raising, this scale relative to company size is material. Execution remains uncertain; Jefferies has no placement guarantee.
Extracted items
- 2.02 results / earnings
- 8.01 other event
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.